M. A. Schickli

Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.

B. Ramaswamy, A. Noonan, Junan Li, 2020, Clinical breast cancer.

Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer

M. Lustberg, Michael Berger, C. Vargo, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.